drugset / Trial / NCT03220074
Linezolid for Treatment of Nontuberculous Mycobacterial Diseases
NaSingle-groupOpen-labelTreatment
Summary
A prospective open study to determine the efficacy and tolerability of oral linezolid 600mg./day for the treatment of 40 patients with nontuberculous mycobacterial diseases will be conducted at Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Timeline
- Start
- 2017-12-15
- Primary completion
- 2021-06-15
- Completion
- 2022-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linezolid | Other / unclassified | 600 mg | Oral |
| Background | Azithromycin | Small molecule | — | Oral |
| Background | Ciprofloxacin | Small molecule | — | Oral |
| Background | Clarithromycin | Small molecule | — | Oral |
| Background | Levofloxacin | Small molecule | — | Oral |